Analystreport

Menlo Therapeutics (NASDAQ: MNLO) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $11.00 price target on the stock.

MENLO THERAPEUTICS INC COMMON  (MNLO) 
Last menlo therapeutics inc common earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.menlotherapeutics.com/investor-relations